ICU Medical Reports Officer Compensation Changes

TL;DR

**ICU Medical just filed an 8-K about changes to executive pay and potential officer/director shifts, keep an eye on leadership.**

AI Summary

ICU Medical, Inc. filed an 8-K on February 29, 2024, reporting events that occurred on February 28, 2024. The filing pertains to changes in compensatory arrangements for certain officers, as well as potential departures or elections of directors or officers. The company, based in San Clemente, California, operates under the SIC code 3841 for Surgical & Medical Instruments & Apparatus.

Why It Matters

Changes in executive compensation and officer roles can signal shifts in company strategy or financial health, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in executive compensation and officer roles can introduce uncertainty regarding leadership stability and future strategic direction.

Key Players & Entities

• ICU MEDICAL INC/DE (company) — Registrant
• February 28, 2024 (date) — Date of earliest event reported
• February 29, 2024 (date) — Filing date
• 951 Calle Amanecer , San Clemente , California 92673 (company) — Business address of ICU Medical, Inc.
• 001-34634 (company) — Commission File Number

FAQ

Key Financial Figures

• $0.10 — ich registered Common stock, par value $0.10 per share ICUI The Nasdaq Stock Market

Filing Documents

• icui-20240228.htm (8-K) — 29KB
• 0000883984-24-000007.txt ( ) — 151KB
• icui-20240228.xsd (EX-101.SCH) — 2KB
• icui-20240228_lab.xml (EX-101.LAB) — 24KB
• icui-20240228_pre.xml (EX-101.PRE) — 12KB
• icui-20240228_htm.xml (XML) — 3KB

From the Filing

icui-20240228 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) 02/28/2024 ICU MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 001-34634 33-0022692 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 951 Calle Amanecer , San Clemente , California 92673 (Address of principal executive offices) (Zip Code) ( 949 ) 366-2183 Registrant's telephone number, including area code N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common stock, par value $0.10 per share ICUI The Nasdaq Stock Market LLC (Global Select Market) Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On February 28, 2024, Mr. William Seeger notified the board of directors (the "Board") of ICU Medical, Inc. (the "Company") that he will retire from the board of directors of Smiths Group plc ("Smiths") on May 31, 2024 and, in anticipation of his retirement, tendered his resignation from the Company Board and a member of the Audit and Compliance Committee of the Company Board as Smiths' nominated director, effective immediately. Mr. Seeger's resignation did not result from any disagreement with the Company or any matter relating to the Company's operations, policies or practices. Smiths Group retains the right to designate a board member as long as Smiths Group beneficially owns at least 5% of the outstanding shares of common stock of the Company as more fully described in the Shareholders Agreement dated January 6, 2022 between the Company and Smiths Group. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ICU MEDICAL, INC. Date: February 29, 2024 By: /s/ Brian M. Bonnell Brian M. Bonnell Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR